The Discounted Cash Flow (DCF) valuation of Cellectis SA (ALCLS.PA) is (26.28) EUR. With the latest stock price at 2.71 EUR, the upside of Cellectis SA based on DCF is -1071.4%.
Based on the latest price of 2.71 EUR and our DCF valuation, Cellectis SA (ALCLS.PA) is a sell. selling ALCLS.PA stocks now will result in a potential gain of 1071.4%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 4.8% - 7.2% | 6.0% |
| Long-term Growth Rate | 3.0% - 4.6% | 3.8% |
| Fair Price | (223.84) - (14.61) | (26.28) |
| Upside | -8375.2% - -640.0% | -1071.4% |